A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over ...
Embecta (EMBC) is a medical devices company focused on diabetes management. It offers a variety of pen needles, syringes, and other assorted tools to help diabetic patients. A much larger company, ...
Embecta Corp. (EMBC) faces a challenging fiscal 2026, with flat revenue and earnings growth expected - after a strong fiscal 2025. EMBC's weak outlook is driven by cannula costs, modest volume ...
Earlier this year it appeared that Embecta, a diabetes care company that spun off from BD in 2022, was finally back on track after a rocky 2025. The Parsippany, NJ-based company’s fiscal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results